Recent developments in Helicobacter pylori vaccination

Scandinavian Journal of Gastroenterology, Supplement

Volumn 36, Issue 234, 2001, Pages 15-21

  Kusters, J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adjuvant; Animal model; Helicobacter pylori; Review; Vaccines

Indexed keywords

ADJUVANT; ANTIBIOTIC AGENT; HELICOBACTER PYLORI VACCINE; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE; BACTERIAL VACCINE;

ANTIBIOTIC RESISTANCE; B CELL LYMPHOMA; BACTERIAL COLONIZATION; CELLULAR IMMUNITY; CHRONIC GASTRITIS; CONFERENCE PAPER; DRUG COST; GRAM NEGATIVE INFECTION; HUMAN; INFECTION PREVENTION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH LYMPHOMA; TH1 CELL; TH2 CELL; VACCINATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNOLOGY; REVIEW;

BACTERIAL VACCINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; VACCINATION;

EID: 0034746956     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201753265406     Document Type: Conference Paper

References (17)

1. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991;13:42-59.
2. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996;348:150-4.
3. Anonymous. Infection with Helicobacter pylori. IARC Monosr Eval Carcinog Risks Hum 1994;61:177-240.
4. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41.
5. Rupnow MF, Owens DK, Shachter R, Parsonnet J. Helicobacter pylori vaccine development and use: a cost-effectiveness analysis usine the Institute of Medicine methodology. Helicobacter 1999;4:272-80.
6. Macdonald TT. The worm turns on Helicobacter pylori. Gut 2001;48:10-1.
7. Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, Nagler-Anderson C. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced castric atrophy. Nature Med 2000;6:536-42.
8. El Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
9. Sugiyama T, Asaka M. Overshift towards T helper (TH)1 cells induces gastric mucosal injury: immunopathology of Helicobacter pylori-infecled gastric mucosa. J Gastroenterol 1999;34:651-2.
10. Crabtree J. Eradication of chronic Helicobacter pylori infection by therapeutic vaccination. Gut 1998;43:7-8.
11. Hone D, Hackett J. Vaccination against enteric bacterial diseases. Rev Infect Dis 1989;11:853-77.
12. Ernst PB, Pappo J. Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges. Curr Pharm Des 2000;6:1557-73.
13. Whary MT, Palley LS, Batchelder M, Murphy JC, Yan L, Taylor NS, et al. Promotion of ulcerative duodenitis in young ferrets by oral immunization with Helicobacter mustelae and muramyl dipeptide. Helicobacter 1997;2:65-77.
14. Guy B, Hessler C, Fourage S, Haensler J, Vialon-Lafay E, Rokbi B, Millet MJ. Systemic Immunization with urease protects mice against Helicobacter pylori infection. Vaccine 1998;16:850-6.
15. Blanchard TG, Czinn SJ, Nedrud JG. Host response and vaccine development to Helicobacter pylori infection. Curr Topics Microbiol Immunol 1999;241:181-213.
16. Pizza M, Giuliani MM, Fontana MR, Monaci E, Douce G, Dougan G, et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 2001;19:2534-41.
17. Jiang B, Jordana M, Xing Z, Smaill F, Snider DP, Borojevic R, et al. Replication-defective adenovirus infection reduces Helicobacter felis colonization in the mouse in a gamma interferon- and interleukin-12-dependent manner. Infect Immun 1999;67:4539-14.